Evidation Health

What Evidation Health does

Evidation Health, Inc. is a private, venture-backed real-world health data company founded in 2012 and headquartered in San Mateo, California. The company operates a direct-to-participant platform that engages a community of approximately 5 million individuals across 97% of U.S. ZIP codes through its consumer mobile application (formerly Achievement, now the Evidation App), capturing longitudinal, multimodal real-world data including electronic health records and claims, demographics and social determinants of health, patient-reported outcomes, molecular data from biospecimens, and continuous digital measures from wearables. The platform supports 20+ condition-specific cohorts spanning cardiometabolic, autoimmune, dermatology, and additional therapeutic areas, and has powered 140+ real-world studies yielding 100+ peer-reviewed publications.

Name

Evidation Health

Legal name

Evidation Health, Inc.

Website

https://evidation.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Evidation Health operates a direct-to-participant real-world data platform used by life sciences companies to capture longitudinal, multimodal health data from a consented community of 5 million individuals across 97% of US ZIP codes.

Ownership category

akta.pro rank

Headquarters

HQ city

San Mateo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Life Sciences Research Partnerships: Evidation partners with pharmaceutical and life sciences companies to provide real-world data and insights. Companies pay for access to longitudinal cohorts, research services, and data analysis. Partners include Eli Lilly, Johnson & Johnson, Sanofi, Genentech, Jazz Pharmaceuticals, and Alexion AstraZeneca Rare Disease.
2. Prospective Studies and Data Services: Evidation conducts real-world studies on behalf of life sciences clients, generating peer-reviewed publications and evidence for drug development and commercialization
3. Patient Recruitment Services: Clinical trial and research recruitment services connecting sponsors with engaged, diverse participant populations across 97% of US ZIP codes

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Evidation operates an AI-enabled multimodal real-world data platform that connects directly with approximately 5 million individuals across 97% of US ZIP codes to capture continuous health data, including clinical (EHR/claims), demographics and SDOH, condition and treatment experience, patient-reported outcomes, molecular/biospecimen, and wearable digital measures. The platform powers condition-specific longitudinal cohorts (cardiometabolic, autoimmune, dermatology, and 20+ additional therapeutic areas) sold to life sciences customers as subscription research partnerships, prospective study services, and patient recruitment offerings.

Product overview

Evidation offers a unified privacy-first digital health measurement and engagement platform built on direct, ongoing connections with millions of individuals (5 million+ across 97% of U.S. ZIP codes). The platform integrates multiple data types — clinical data (EHR and claims), demographics, patient-reported outcomes, molecular data from biospecimens, and continuous digital measures from wearables — to generate multimodal real-world health data. The core Evidation Real-World Data Platform is complemented by the Evidation App (formerly Achievement App), a consumer mobile application through which individuals contribute data, receive personalized insights, and earn rewards. Evidation operates multiple condition-specific longitudinal cohorts: the Cardiometabolic Health and Weight Management Cohort (160,000+ individuals tracking GLP-1 use and metabolic health), the Autoimmune Research Cohort (3,500+ enrolled, with a dedicated AI-enabled Temporal Proteomics Platform for multiomics research), and the Dermatology Cohort (100,000+ individuals). A 1upHealth FHIR integration enables consented health record data linkage. The platform uses data science and machine learning to translate everyday insights into health guidance, treatments, and tools, supports 140+ real-world studies, and has produced 100+ peer-reviewed publications.

Differentiator

Problem solved

Functional benefit

Products and services

• Evidation Real-World Data Platform

Quantifiable outcome

• 140+ real-world studies supported on platform
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and supporting.

• 1upHealthcoreTechnology or Integration · 17 October 2024Long-term partnership to advance patient-centered, real-world health research through consented data sharing and linkage. Evidation integrates 1up Patient Connect to allow individuals to permission their health record data, combined with Evidation's consented longitudinal data from everyday life to create comprehensive health journey understanding.
• TrialbeesupportingChannel Partner/ Reseller/ Distributor · 17 September 2024Partnership to accelerate and diversify clinical research recruitment by connecting Trialbee's recruitment capabilities with Evidation's engaged participant community.
• ApplecoreTechnology or IntegrationPartnership with Apple and Eli Lilly generated 16 terabytes of data demonstrating the potential of digital biomarkers from wearables and smartphones for Alzheimer's disease research and early detection.
• The Michael J. Fox FoundationcoreStrategic or Co-development PartnerPartnership for Parkinson's disease research leveraging digital measures and direct-to-participant data collection capabilities.
• The American Heart AssociationcoreStrategic or Co-development PartnerPartnership to advance cardiovascular health research through direct engagement with participant populations and real-world data collection.
• Duke Big Ideas LabsupportingStrategic or Co-development PartnerPartnership to increase representation of underserved populations and improve adherence in digital health studies through collaborative analytics development.
• Eli LillycoreStrategic or Co-development PartnerPartnership to find digital measures of health; generated 16 terabytes of data through Apple collaboration for Alzheimer's disease research.
• Johnson & JohnsoncoreStrategic or Co-development PartnerCollaboration on the Heartline Study with Apple; real-world evidence generation for cardiovascular health research.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Flatiron Health: Roche-owned real-world evidence platform focused on oncology EHR and claims data; comparable as a pharma-facing RWE company with deep EHR-derived longitudinal datasets and similar enterprise sales motion.
• Tempus Labs: AI-powered precision medicine company combining multimodal clinical and molecular data for pharma and providers; directly comparable on data modality (EHR + omics + imaging) and life sciences customer base.
• Aetion: Real-world evidence analytics platform used by biopharma and regulators; comparable as a software-enabled RWE vendor serving the same pharma R&D and commercial use cases.

Broad incumbents

• IQVIA: Largest CRO and real-world data incumbent with deep claims, EHR, and clinical operations; competes broadly with Evidation on pharma RWD and evidence generation, with much broader portfolio scale.
• Medidata (Dassault Systèmes): Clinical trial technology platform (Rave EDC, eCOA, RTSM) serving pharma sponsors; overlaps with Evidation's clinical research and ePRO-adjacent capabilities as part of a much broader trial suite.
• Verily (Alphabet): Alphabet life sciences subsidiary running consumer and clinical research platforms (e.g., Baseline, Project Baseline); comparable on direct-to-participant health data at population scale, with substantially larger capital backing.
• Veradigm: EHR-linked real-world data and life sciences analytics vendor; comparable as an EHR-derived RWD provider supplying pharma evidence and commercial teams, though without the consumer-first data layer.

Emerging players

• 23andMe: Consumer-facing genomics company with a research-consented participant base and pharma therapeutics partnerships; comparable on direct-to-consumer health data + pharma R&D model, though focused on genomics rather than multimodal clinical data.
• PatientsLikeMe: Online patient community and real-world patient-reported outcomes platform historically used by pharma for research; shares the direct-to-patient longitudinal PRO data model that Evidation extends with wearables and biospecimens.

Others

• Health Catalyst: Healthcare data and analytics platform serving providers and life sciences; adjacent rather than direct, sharing the enterprise health data infrastructure layer but focused on provider analytics more than consumer-first RWD.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCWqWO2eAZxdhhuYDQHOKjRQ/featured
• Facebookfacebook.com/myEvidation
• LinkedInlinkedin.com/company/evidation-health
• Instagraminstagram.com/my_evidation
• Pinterestpinterest.com/myEvidation/_created
• TikToktiktok.com/@evidation
• Xx.com/evidation

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds11 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evidation Health